 |
PDBsum entry 3eem
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
3eem
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Probing the active site of candida glabrata dihydrofolate reductase with high resolution crystal structures and the synthesis of new inhibitors.
|
 |
|
Authors
|
 |
J.Liu,
D.B.Bolstad,
A.E.Smith,
N.D.Priestley,
D.L.Wright,
A.C.Anderson.
|
 |
|
Ref.
|
 |
Chem Biol Drug Des, 2009,
73,
62-74.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Candida glabrata, a fungal strain resistant to many commonly administered
antifungal agents, has become an emerging threat to human health. In previous
work, we validated that the essential enzyme, dihydrofolate reductase, is a drug
target in C. glabrata. Using a crystal structure of dihydrofolate reductase from
C. glabrata bound to an initial lead compound, we designed a class of biphenyl
antifolates that potently and selectively inhibit both the enzyme and the growth
of the fungal culture. In this work, we explore the structure-activity
relationships of this class of antifolates with four new high resolution crystal
structures of enzyme:inhibitor complexes and the synthesis of four new
inhibitors. The designed inhibitors are intended to probe key hydrophobic
pockets visible in the crystal structure. The crystal structures and an
evaluation of the new compounds reveal that methyl groups at the meta and para
positions of the distal phenyl ring achieve the greatest number of interactions
with the pathogenic enzyme and the greatest degree of selectivity over the human
enzyme. Additionally, antifungal activity can be tuned with substitution
patterns at the propargyl and para-phenyl positions.
|
 |
|
|
|
|
 |